Lv2
140 积分 2023-11-15 加入
Efficacy of anifrolumab across organ domains in patients with moderate-to-severe systemic lupus erythematosus: a post-hoc analysis of pooled data from the TULIP-1 and TULIP-2 trials
10小时前
待确认
An Extracellular Humanized IFNAR Immunocompetent Mouse Model for Analyses of Human Interferon Alpha and Subtypes
4个月前
已完结
A novel humanized cutaneous lupus erythematosus mouse model mediated by IL-21-induced age-associated B cells
4个月前
已完结
Bispecific and multispecific antibodies in oncology: opportunities and challenges
6个月前
已完结
Novel strategies in the treatment of acute lymphoblastic leukaemia
6个月前
已完结
Trispecific CD19-CD20-CD22–targeting duoCAR-T cells eliminate antigen-heterogeneous B cell tumors in preclinical models
6个月前
已完结
Preclinical characterization and comparison between CD3/CD19 bispecific and novel CD3/CD19/CD20 trispecific antibodies against B-cell acute lymphoblastic leukemia: targeted immunotherapy for acute lymphoblastic leukemia
7个月前
已完结
New immune cell engagers for cancer immunotherapy
10个月前
已完结
T-cell-engaging bispecific antibodies in cancer
11个月前
已完结
Mezigdomide plus Dexamethasone in Relapsed and Refractory Multiple Myeloma
1年前
已完结
皖公网安备34019202002308
